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Clathrin Structure Characterized with Monoclonal 
Antibodies. 
II. Identification of In Vivo Forms of Clathrin 
FRANCES M. BRODSKY 
Becton Dickinson Immunocytometry Systems, Mountain View, California 94039 
ABSTRACT Clathrin was isolated from detergent-solubilized, biosynthetically radiolabeled cells 
by immunoprecipitation with anti-clathrin monoclonal antibodies. Immunoprecipitates ob- 
tained after pulse-chase labeling demonstrated that after biosynthesis the LCa light chain of 
clathrin could be found either complexed to heavy chain or in a free pool (not associated 
with heavy chain) which decreased steadily over time. More than half of the free LCa 
disappeared within the first hour after biosynthesis, but some was still detectable after several 
hours. Incorporation of clathrin LCa light chain and heavy chain into coated vesicles was 
coordinate and increased up to 4 h after biosynthesis. Comparison of these kinetics suggested 
that once incorporated into coated vesicles, LCa and heavy chain did not dissociate, even 
during depolymerization of the vesicle. There was also little apparent degradation of clathrin 
found in coated vesicles for up to 22 h after biosynthesis. Immunoprecipitation with anti- 
clathrin monoclonal antibodies was carried out after fractionation of continuously radiolabeled 
cell lysates using two different sizing columns. These experiments indicated that the triskelion 
form of clathrin that has been isolated from coated vesicles in vitro also exists in vivo. They 
also confirmed the existence of a transient but detectable pool of newly synthesized free LCa 
light chain. 
Coated pits and coated vesicles are the structures that result 
from membrane invagination during endocytosis and intra- 
cellular membrane translocation (1). To form these organelles, 
the protein clathrin polymerizes atthe membrane surface (2). 
After formation of an endocytic oated vesicle, the clathrin 
depolymerizes within a few minutes, and the resulting un- 
coated vesicle (endosome) is acidified (3-5). This sequence of 
events suggests that within a cell there must be a pool of 
depolymerized clathrin in equilibrium with polymerized 
clathrin. The amount of depolymerized clathrin detectable in
the cytoplasm seems to vary depending on the cell type 
examined. It has been demonstrated that in some cell types 
up to 70% of the clathrin in the cell is not membrane 
associated (6). However, in other cell types large patches of 
plasma membrane-associated clathrin have been observed (2, 
7), and it has been proposed that the clathrin subunits rear- 
range on the membrane to form coated pits and initiate 
internalization (2). 
One question raised by these data is, What is the molecular 
form of the clathrin subunits involved in the polymerization- 
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depolymerization cycle in vivo? Clathrin is composed of a 
heavy chain of 180 kD and two light chains, LCa and LCb, of 
32-38 kD (8-10). It has been shown that the molecular unit 
of clathrin that is stripped off coated vesicles under nonphys- 
iological conditions is a "triskelion" consisting of three clath- 
rin heavy chains and three light chains (9-11). These struc- 
tures apparently have a random distribution of the two forms 
of clathrin light chain (l 2). Thus far, no evidence has been 
presented to demonstrate hat disassembled clathrin in vivo 
also has this structure. The possibility remains that free pools 
of clathrin heavy chain or light chains or even heavy chain- 
light chain monomers may exist in vivo, and that these 
regulate coated vesicle assembly directly or indirectly by reg- 
ulating triskelion assembly. 
In this study, the form of in vivo clathrin has been exam- 
ined. The monoclonal anti-clathrin antibodies described in 
the companion article have been used to immunoprecipitate 
biosynthetically radiolabeled clathrin present in cells in tissue 
culture (13). Pulse-chase labeling was used to examine assem- 
bly of clathrin subunits after biosynthesis. Fractionation of 
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labeled cell lysate was used to determine the size of the clathrin 
molecules involved in steady state polymerization and depo- 
lymerization. These experiments demonstrated the existence 
of a transient pool of free LC~ light chain, after biosynthesis, 
as well as the existence of clathrin triskelions in vivo. 
MATERIALS AND METHODS 
Cell Lines, Media, and Reagents 
The LB cell line, an Epstein Ban" virus-transformed human B cell line, was 
a gift from V. Engelhard (University of Virginia, Charlottesville). The BL-3 cell 
line, grown from bovine leukemia cells, was a gift from G. Theilen (University 
of California, Davis). These cells were grown in RPMI 1640 with 10% fetal calf 
serum and no antibiotics. For biosynthetic radiolabeling, amino acid-free 
media were prepared from the RPMI-1640 Select-Amine kit (No. 300-7402, 
Gibeo Laboratories, Grand Island, NY) and used with 5% dialyzed fetal calf 
serum. The Anti-Leu 4, Anti-Leu 10, and anti-Igh5b monoclonal antibodies, 
used as control antibodies of the IgG~ isotype, were obtained in purified form 
from Becton Dickinson Immunocytometry Systems. Their respective target 
antigens are a human T cell surface glycoprotein, a human B cell surface 
glycoprotein (HLA-DQ), and an allotypic determinant of mouse IgD (14-16). 
For immune complex formation, sheep anti-mouse IgG (Cappel 0211-1744, 
Cappel Laboratories, Cochranville, PA) was used. All other antibodies were 
purified from mouse ascites fluid as previously described (17). Fixed Staphylo- 
coccus aureus (Staph A) ~ bacteria were from The Enzyme Center (Boston, MA). 
IMMUNE COMPLEX METHOD (21, 22): Immune complexes were 
formed with 200 ~g purified monoclonal ntibody and 300 #l sheep anti-mouse 
immunoglobulin (specific antibody at 7 mg/ml) and washed in 50 mM Tris, 
pH 8.0, 200 mM NaCl, l mM EDTA, 0.5% NP40 (complex buffer). Aliquots 
of cell lysate were preincubated with immune complexes formed from a control 
antibody (anti-Igh5b). These were removed by centrifugation, and specific 
immune complexes were added. After incubation for 1 h at 4°C, lysate contain- 
ing specific immune complexes was layered on a step gradient that consisted, 
from bottom to top, of 1 ml 40% sucrose, l0 mM Tris, pH 8.0, l ml 30% 
sucrose, 0.2% NP40, l0 mM Tris, pH 8.0, l ml 20% sucrose, 0.5 M NaCl, 
0.2% NP40, t0 mM Tris, pH 8.0, and 1 ml 10% sucrose, 0.5% NP40, 10 mM 
Tris, pH 8.0, and centrifuged at2,000 g in a swinging bucket rotor. The pelleted 
complexes were washed once in complex buffer and then dissolved in the 
sample buffer used for electrophoresis. 
Electrophoresis and Autoradiography 
SOS PAGE was carried out according to the method of Laemmli (23). All 
gels were 10% acrylamide. Gels were stained with Coomassie Brilliant Blue R 
and, after destaining (13), treated with Enlightening (New England Nuclear). 
Gels were dried and exposed to XAR-5 Kodak film using an intensifying screen 
(Dupont Lightening Plus, DuPont Photo Products Division-X-Ray, Burbank, 
CA). Molecular weight markers (Pharmacia Fine Chemicals, Piscataway, NJ) 
used were phosphorylase b (94 kD), bovine serum albumin (67 kD), ovalbumin 
(43 kD), carbonic anhydrase (30 kD), soybean trypsin inhibitor (20. l kD), and 
a-lactalbumin (14.4 kD). 
Biosynthetic Radiolabeling 
C O N Z I S U O U S L A B E L I N G ( 18 ) : Lymphoid cell line cells were washed 
once in RPMI 1640 medium without he amino acid used for labeling. They 
were resuspended at2 x l06 cells/ml in fresh amino acid free-medium and 
incubated for 30 rain at 37"C, and then the radioactive amino acid at 1 mCi 
per 2 x l07 cells was added. [3~S]Methionine (>800 Ci/mmol, No. NEG-009T, 
New England Nuclear, Boston, MA), [3H]leucine (120-190 Ci/mmol, 
TRK.683, Amersham Corp., Arlington Heights, IL) or [3H]lysine (80-1 l0 Ci/ 
retool, NET-376, New England Nuclear) were used. After 4 h of incubation at 
37°C, cells were washed once in cold phosphate-buffered saline, pH 7.4, and 
then resuspended at 2 x l0 T cells/ml in buffer I (10 mM Tris, pH 7.3, 1 mM 
MgCI2, 0.5% Nonidet P-40 [NP40], 0.005% phenylmethylsulfonyl fluoride) 
(19), buffer II (t0 mM Tris, pH 8.0, 200 mM NaCI, 1 mM EDTA, 1 mM 
EGTA, 0.5 % NP40, 0.005% phenylmethylsulfonyl fluoride), or buffer III (10 
mM 2-(N-morpholino)ethane sulfonic acid, pH 6.2, 200 mM NaCl, 2.5 mM 
MgCI2, 2 mM CaCl2, 0.5% NP40, 0.005% phenylmethylsulfonyl fluoride). 
After 30 rain at 4°C, solubilized cells were microfuged for 15 rain, and the 
pellet was discarded. 
PULSE-CHASE LABELING (20): Lymphoid cell line cells (4 X 107)were 
washed once in methionine-free medium, resuspended at 4 x 10~/ml in fresh 
methionine-free medium, and incubated at 37"(? for 30-60 rain. Cells were 
then centrifuged, resuspended at 4 x l0 T cells/ml in methionine-free medium, 
and 2 mCi [3~S]methionine was added. After 10 rain at 37°C, chase medium 
(RPMI-1640, 10% fetal calf serum, 75 t,g/ml L-methionine) was added, and 4 
x l06 cells were removed for solubilization at designated chase times, with the 
culture kept at 37°C. Cells were solubilized as above, without washing, in either 
buffer I or buffer II. Results obtained with both solubilization buffers were 
identical. 
TRICHLOROACETIC ACID (TCA) PRECIPITATION: Theamount of 
radioactivity incorporated into protein during biosynthetic labeling was deter- 
mined by precipitation of an aliquot of cell lysate with 10% TCA. Precipitates 
were resuspended in solubilization buffer and counted in Aquasol (New Eng- 
land Nuclear) in a scintillation counter, This procedure was used to monitor 
the pulse-chase labeling and confirm that no further adioactivity was incor- 
porated into protein after the chase medium was added. 
Immunoprecipitation 
STAPH A METHOD (19): Aliquots of cell lysate were preincubated with 
normal rabbit serum and Staph A, which was removed by centrifugation, 
Pretreated lysate was then incubated with specific MAb for 1 h at 4"C. Rabbit 
anti-mouse immunoglobulin serum and Staph A were used to isolate antibody 
antigen complexes. Buffers, washing procedures, and sample lution were the 
same as those described previously (18, 19). 
J Abbreviations used in thispaper. MAb, monoclonal ntibody; NP40, 
Nonidet P-40; Staph A, fixed Staphylococcus aureus bacteria. 
Column Chromatography 
Columns (0.9 cm x 30 cm) of Ultrogel AcA 22 (LKB Instruments Inc., 
Gaithersburg, MD) or Sephacryl S-1000 (Pharmacia Fine Chemicals) were 
equilibrated in buffer II without NP40 for calibration. Protein standards used 
for calibration were molecular weight markers (Bio-Rad No. 151-901 at 3.6 
mg/ml, Bio-Rad Laboratories, Richmond, CA), elathrin triskelions at 200 ug/ 
ml, and coated vesicles at ~2 mg/ml in column buffer with 0.5 mg/ml blue 
dextran. A l-ml sample of each protein standard was applied to each column, 
and l-m1 fractions were collected. The columns were then equilibrated inbuffer 
II with l mg/ml ovalbumin and used repeatedly for fractionation of 1 ml lysate 
from 2 x l07 cells labeled with [35S]methionine for 4 h. The lysate applied to 
the column was preincubated with normal rabbit serum and Staph A or with 
control immune complex. The l-m1 fractions collected were also preincubated 
with normal rabbit serum and Staph A or control immune complex and then 
divided into two aliquots for immunoprecipitation with specific and control 
monoclonal antibodies. For the AcA 22 column runs, the fraction containing 
the peak of blue dextran was noted, and the preceding fraction was counted as 
fraction I. For the S-1000 column separations ofradioactive cell lysate, 5 ~,l of 
each fraction was suspended in Aquasol and counted in a scintillation counter. 
The first fraction containing radioactivity was counted as fraction I. This 
corresponded tofraction l of the calibration runs based on the position of blue 
dextran, the number of fractions collected after the sample was loaded, and the 
bed volume of the column. The clathrin triskelions and coated vesicles used 
for calibration were purified from bovine brain as described by Pearse and 
Robinson (24). 
RESULTS 
Isolation of Biosynthetically 
Radiolabeled Clathrin 
To determine the feasibility of studying in vivo forms of 
clathrin, three MAbs were tested for their ability to immu- 
noprecipitate clathrin from detergent-solubilized, biosynthet- 
ically radiolabeled cells. The specificities of the antibodies 
used in this study are listed in Table I. A human B cell line 
(LB) was grown for 4 h in the presence of [3SS]methionine or
[3H]lysine in appropriately depleted tissue culture media. 
These cells were solubilized in a detergent-containing buffer 
(buffer I), commonly used for solubilizing biosynthetically 
labeled cell surface glycoproteins. Fig. 1 shows the antigens 
immunoprecipitated from [aSS]methionine LB cell lysate us- 
ing the Xl6, X19, and X22 MAbs and Staph A. Results from 
the [3H]lysine-labeled cells were identical, as were results using 
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TABLE I. Monoclonal Antibodies Used in this Study 
Clathrin binding specificity* Species specificity 
Coated 
MAb Subunit Triskelions vesicles Bovine Human Mouse 
CVC.6 + (LCa) + + + - NT 
X16 + (LCa) - - + + + 
Xl 9 + (heavy chain) + + + + NT 
X22 + (heavy chain) + + + + NT 
* MAb reactivity summarized here is based on specificity in immunoprecipitation or immunoaffinity experiments. Reactivity is indicated by +. Lack of reactivity 
is indicated by -.  NT, not tested. 
FIGURE I Clathrin isolated by immunoprecipitation from an 35S- 
labeled human B cell line (LB). Anti-clathrin MAbs X16, X19, and 
X22, and control MAb anti-Leu 4 were combined with aliquots of 
NP40-solubilized LB cells, labeled for 4 h with [3SS]methionine. The 
antibody-antigen complexes were isolated with rabbit anti-mouse 
immunoglobulin serum and Staph A, analyzed by SDS PAGE, and 
the antigen was visualized by autoradiography. Each lane shows 
the antigen immunoprecipitated by the antibody indicated at the 
top of the autoradiograph. The specificities of the antibodies are 
listed in Materials and Methods and Table I. The migration distance 
of standard proteins of known molecular weight and human brain 
clathrin polypeptides are indicated at the left of the autoradiograph. 
The position of Lea light chain isolated from LB cells is indicated at 
the right. 
solubilization buffers II and III, designed to stabilize triskel- 
ions and coated vesicles, respectively. The XI6 antibody, 
which immunoprecipitates free LC. but not intact clathrin 
triskelions, isolated LCa from the cell lysate. This immuno- 
precipitated LC~ was not associated with clathrin heavy chain. 
Note that the molecular weight of the immunoprecipitated 
lymphoid LC~ is lower than that of human brain clathrin LC., 
used as a molecular weight marker, as would be expected for 
nonbrain clathrin (25). The fainter band of -40 kD also seen 
in the X 16 immunoprecipitate was not a consistent compo- 
nent in repeated immunoprecipitations, and its significance 
is unclear. The clathrin immunoprecipitated by anti-heavy 
chain antibodies X19 and X22 appeared to contain heavy 
chain and LC, light chain, but a band at the expected molec- 
ular weight for LCb light chain was barely detectable. To 
investigate this result, XI9 and X22 were used to immuno- 
precipitate clathrin from cells labeled with [3H]lysine or 
[3H]leucine for 3-5 h or from cells labeled with [35S]methio- 
nine for as long as 24 h. In some of these immunoprecipitates 
the LCb band was more clearly visible than in the examples 
shown in Fig. 1, but it was always lighter than the LC, band. 
Its presence did not correlate with the amino acid used for 
labeling, the length of the labeling period, or whether the c ll 
lysate had been frozen before immunoprecipitation, which 
might have caused preferential degradation. The X19 and 
X22 immunoprecipitates also contained a series of polypep- 
tides from 60-150 kD, some of which are presumably clath- 
rin- or coated vesicle-associated proteins. Others correspond 
to bands seen in the immunoprecipitate obtained with a 
control antibody of the same isotype, Anti-Leu 4. 
This initial experiment established that anti-clathrin MAbs 
could be used to immunoprecipitate biosynthetically radio- 
labeled clathrin from cell lysate to study its form in vivo. The 
pulse-chase experiments described below were carried out to 
determine whether the free LCa immunoprecipitated by the 
X 16 antibody represents a diminishing pool of newly synthe- 
sized LCa or is derived from a regenerating stable pool of free 
LCa. Experiments on gel filtration of cell lysate were then 
carded out to determine the size of the heavy chain-LCa 
complex immunoprecipitated by X 19 and X22 and to see if 
a separate pool of free LCa was immunoprecipitated by X 16. 
Fate of Clathrin Polypeptides After Biosynthesis 
The stability of the intracellular pool of LCa detected by 
the X 16 MAb was determined by immunoprecipitation after 
a pulse-chase labeling. Cells were labeled for 10 min with 
[35S]methionine and then diluted in medium containing an 
excess of unlabeled methionine (chase medium). Aliquots of 
cells were solubilized at the time of dilution and at specific 
intervals thereafter. The XI6 (anti-LC,), X22 (anti-heavy 
chain) and control MAbs were combined with these lysates, 
and immunoprecipitated antigen was analyzed by SDS PAGE 
and autoradiography. This experiment was carded out several 
times using the human B cell line, LB, and the bovine 
leukemia line, BL-3. The results were the same for both cell 
lines, and representative experiments are shown in Fig. 2. The 
X 16 and anti-Leu 10 immunoprecipitates w re obtained using 
preformed immune complexes according to the method of 
van Agthoven et al. (21). The X22 and anti-Leu 4 immuno- 
precipitates were isolated with Staph A. The first method 
produced less background immunoprecipitation, as indicated 
by the arrows at the right of the anti-Leu 10 and anti-Leu 4 
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FIGURE 2 Clathrin biosynthesis in BL-3 and LB cells analyzed by pulse-chase labeling and immunoprecipitation. Cells were 
labeled for 10 min with [~SS]methionine. Then chase medium, containing excess unlabeled methionine, was added at time 0. 
The MAbs indicated below each panel were used to immunoprecipitate antigen from aliquots of cells solubilized at the chase 
times indicated at the top of each panel. The prime symbol stands for minutes. Each panel shows an autoradiograph of SDS 
PAGE analysis of the immunoprecipitates. At the left of each panel are the migration positions of the molecular weight markers 
used. At the right of the X16 and X22 panels the immunoprecipitated clathrin components are indicated. HC, heavy chain. At 
the right of the Anti-Leu 10 and Anti-Leu 4 panels the background bands are indicated. The X16 and anti-Leu 10 immunoprecip- 
itates are from pulse-labeled BL-3 cells and were obtained by the immune complex method. The X22 and anti-Leu 4 
immunoprecipitates are from pulse-labeled LB cells and were obtained by the Staph A method. 
autoradiographs. However, the second method gave more 
efficient results with the X22 antibody. The position of the 
LCa polypeptides immunoprecipitated by X 16 is indicated at 
the right of the autoradiograph. The amount of free LCa 
immunoprecipitated began to decrease by 30 min, and grad- 
ual reduction continued for several hours. By l h of chase 
time, less than half of the LCa detected immediately after the 
pulse labeling was present. However, some free LCa could still 
be immunoprecipitated 4 hafter biosynthesis, and it was just 
barely detectable for as long as 7 h after chase medium was 
added. Additional experiments showed that it completely 
disappeared by 8 h. The amount of clathrin heavy chain 
immunoprecipitated by X22 increased up to 4 h after chase 
medium was added and then leveled off. The amount of co- 
precipitated LCa increased with the same kinetics. Although 
some newly synthesized LCa could be found in a free pool 
after biosynthesis, a faint band at the molecular weight of LCa 
could be seen associated with heavy chain in the X22 im- 
munoprecipitates, within l0 min after synthesis. The presence 
of LC~ associated with heavy chain at the time chase medium 
was added was confirmed by longer exposure of the X22 
autoradiograph. 
Sizing Clathrin Molecules in Cell Lysates 
To determine the size of clathrin molecules present in vivo, 
columns (0.9 x 30 cm) composed of gel filtration media 
Ultrogel AcA 22 and Sephacryl S-1000 were used. These 
columns were calibrated with known molecular weight mark- 
ers, with clathrin triskelions purified from bovine brain, and 
with bovine brain coated vesicles, which were applied to the 
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columns in the volume to be used for the test sample. After 
calibration, radiolabeled cell lysates were applied to the col- 
umns and fractions were collected. The MAbs X22 (anti- 
heavy chain), CVC.6 (anti-LCa in triskelions), and X l6 (anti- 
free LCa) were used to immunoprecipitate clathrin from these 
fractions and thereby determine the elution position of in 
vivo clathrin. X22 and CVC.6 were chosen because they 
reacted with clathrin in triskelion and coated vesicle form 
when tested as immunoaffinity columns. X16 was used to 
confirm the existence of a free pool of the light chain. The 
bovine lymphoid cell line, BL-3, was used for radiolabeled 
lysate preparation because the CVC.6 antibody, which im- 
munoprecipitates LCa associated with clathrin heavy chain, 
reacts only with bovine clathrin. In a typical experiment, 
lysate was applied to a column and the fractions collected 
were immunoprecipitated with a specific antibody and a 
control antibody. The fractions analyzed in the experiments 
described below are all numbered starting with the void 
volume and therefore represent equivalent elution positions 
off of each column. 
Fig. 3 shows results obtained with the AcA 22 sizing col- 
umn. The calibration profile, seen in Fig. 3A, shows resolution 
of molecular weight markers in the 17 to 670 kD range. 
Calibration with purified clathrin triskelions and coated ves- 
icles showed that both species co-eluted in the void volume 
with blue dextran, even though the buffer was at pH 8.0 and 
contained chelating agents to stabilize the triskelion form 
(12). Lysate was applied to the column, and fractions from 
FIGURE 3 The size of in vivo 
clathrin examined by AcA 22 frac- 
tionation of radiolabeled cell ly- 
sate. Protein standards of known 
molecular weight were separated 
on a column (0.9 x 30 cm) of 
UItrogel AcA 22, and 15 1-ml frac- 
tions were collected. The absor- 
bance profile of the column 
eluate is shown in A. The elution 
position of each protein was con- 
firmed by SDS PAGE analysis. The 
proteins applied to the column 
were thyroglobulin (670 kD), IgG 
(158 kD), ovalbumin (44 kD), my- 
oglobin (17 kD), and vitamin B-12 
(1.4 kD). Purified clathrin triskel- 
ions and coated vesicles eluted in 
the void volume (not shown). Cell 
lysate (1 ml) prepared from [3sS]- 
methionine-labeled BL-3 cells (2 
x 107 ) was fractionated on the 
same UItrogel AcA 22 column, 
and corresponding fractions were 
collected. These fractions were 
divided into two aliquots and 
used for immunoprecipitation 
with anti-clathrin and control 
MAb anti-Leu 10. Immunoprecip- 
itates were analyzed by SDS 
PAGE and autoradiography. B 
shows the clathrin heavy chain 
(HC) region of the autoradiograph 
of X22 immunoprecipitates. C
shows the LCa light chain region 
of the autoradiograph of X16 im- 
munoprecipitates. D shows the 
region of the autoradiograph ot 
anti-Leu 10 immunoprecipitates 
corresponding to B and C. Im- 
munoprecipitates shown in C and 
D were obtained from the same 
fractions. The control immuno- 
precipitates for the results ~n i; 
were identical to those shown in 
D. The migration of molecular 
weight markers is indicated at the 
right of each panel. 
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one run were immunoprecipitated with X22 (Fig. 3B) and 
anti-Leu 10. Fractions from a second run were immunopre- 
cipitated with CVC.6 and anti-Leu 10. A third run was 
immunoprecipitated with X 16 (Fig. 3C) and anti-Leu 10 (Fig. 
3D). Since the anti-Leu 10 results were similar, only one 
example is shown. The CVC.6 and X22 antibodies both 
immunoprecipitated clathrin (heavy chain and LCa light 
chain) from the fractions containing blue dextran. The peak 
trailed into the column, but there was no additional peak of 
heavy chain clathrin precipitated ata lower molecular weight 
than triskelions. The X 16 MAb immunoprecipitated free LCa 
light chain in a separate peak of lower molecular weight han 
triskelions. 
Since purified coated vesicles eluted off the AcA 22 column 
at the same position as clathrin triskelions, it was of interest 
to repeat hese experiments on a column that would distin- 
guish between triskelions and coated vesicles. The S-1000 
column was used for this purpose. Calibration of this column 
is shown in Fig. 4. The peak of triskelion elution was con- 
tained in fractions 10-12 (Fig. 4B), and the peak of coated 
vesicle lution was located in fractions 6-8 (Fig. 4C). Analysis 
of immunoprecipitates from two lysate runs on the S-1000 
column (Fig. 5) shows that the peak of clathrin isolated by 
the CVC.6 antibody (Fig. 5A) spanned the positions ofelution 
of the coated vesicle and triskelion peaks. The clathrin peak 
isolated by X22 (Fig. 5B) overlapped primarily with the coated 
vesicle peak. Again, the clathrin immunoprecipitated by both 
antibodies (CVC.6 and X22) contained heavy chain and LCa 
light chain. Control autoradiographs (not shown) of immu- 
noprecipitates obtained with anti-Leu l0 from these fractions 
had essentially no bands in the heavy chain region. 
DISCUSSION 
In the experiments described above, anti-clathrin MAbs have 
been used to immunoprecipitate clathrin directly from cell 
FIGURE 4 S-1000 fractiona- 
tion of (A) standard proteins, 
(B) clathrin triskelions, and 
(C) coated vesicles. Protein 
standards of known molec- 
ular weight were separated 
on a column (0.9 x 30 cm) 
of Sephacryl S-1000, and 15 
1-ml fractions were col- 
lected. The absorbance pro- 
file of the column eluate is 
shown in A. The proteins ap- 
plied to the column were the 
same as described in the leg- 
end to Fig. 3. Their elution 
position was confirmed by 
SDS PAGE. Clathrin triskel- 
ions (B) and coated vesicles 
(C), purified from bovine 
brain, were applied to the 
same Sephacryl S-1000 col- 
umn. Corresponding frac- 
tions were collected, and a 
20-~1 sample of each fraction 
was analyzed by SDS PAGE. 
Gels were stained with Coo- 
massie Blue and photo- 
graphed. The migration po- 
sitions of the clathrin heavy 
chain (HC) and light chains 
(LCa and LCb) are indicated 
at the left of B and C. 
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FIGURE 5 The size of in vivo clathrin examined by S-1000 fraction- 
ation of radiolabeled cell lysate. Cell lysate (1 ml) prepared from 
[35S]methionine-labeled BL-3 cells (2 x 107) was fractionated on the 
Sephacryl S-1000 column described in Fig. 4, and corresponding 
fractions were collected. These fractions were divided into two 
aliquots and used for immunoprecipitation with anti-clathrin and 
control MAb anti-Leu 10. Immunoprecipitates were analyzed by 
SDS PAGE and autoradiography. A shows the region of the auto- 
radiograph of the CVC.6 immunoprecipitates that contain the clath- 
rin heavy chain (HC). B shows the corresponding region of the 
autoradiograph of X22 immunoprecipitates. These immunoprecip- 
itates were obtained from different sets of fractions collected after 
identical lysate fractionations. The bands shown are unique as 
compared with those of autoradiographs of anti-Leu 10 immuno- 
precipitates from the same fractions (not shown). The migration 
position of the molecular weight marker, phosphorylase b (94 kD), 
is shown at the left of both panels. 
lysates to examine the forms of clathrin that exist in vivo. 
Using anti-clathrin heavy chain MAbs (X19 and X22) and 
an MAb (X 16) that immunoprecipitates LCalight chain only 
if it is not associated with heavy chain, it was demonstrated 
that the LCa light chain can be found associated with heavy 
chain or in free form. To determine the size of the immuno- 
precipitated structures and the kinetics of their intracellular 
existence, immunoprecipitation was carried out after cell 
lysate fractionation by column chromatography or after pulse- 
chase labeling of the cells used to prepare lysates. Lysate 
fractionation on a column of Ultrogel AcA 22 showed that 
clathrin heavy chain associated with LCa light chain localized 
to the void volume, as determined by immunoprecipitation 
with anti-heavy chain MAb X22 and CVC.6, which prefer- 
entially immunoprecipitates LC~ in association with heavy 
chain. Both antibodies reacted exclusively with clathrin in 
this peak. Calibration with purified triskelions and coated 
vesicles howed that both structures eluted in the void volume, 
demonstrating that triskelions that are -645 kD (9, 10) eluted 
at a higher apparent molecular weight, perhaps as a result of 
their unusual geometry. The X I6 MAb (anti-free LC~) iso- 
lated LCa light chain from a separate peak, eluting at lower 
molecular weight. This elution zone corresponded to fraction- 
ation of the 44-158-kD protein standards, which is higher 
than would be expected for a single free light chain. However 
it has been shown previously that on a Spherogel TSK 3000 
column, free clathrin light chains run with an apparent mo- 
lecular weight of 90 kD (26). They appear to have similar 
properties in this system. Lysate from cells labeled continu- 
ously for 4 h was then applied to a Sephacryl S-1000 column, 
which resolves purified coated vesicles from triskelions, run- 
ning at a position corresponding to their expected molecular 
weight on this particular column. The X22 MAb immuno- 
precipitated clathrin primarily from the elution position of 
coated vesicles. The CVC.6 MAb isolated clathrin, which co- 
migrates with both coated vesicles and triskelions. Within the 
limit of the resolution of the AcA 22 and S-1000 columns, 
and the specificities of the antibodies used, no other peaks 
containing clathrin heavy chain in association with light chain 
were identified. These results indicate that the triskelion and 
coated vesicle forms identified for depolymerized and polym- 
erized clathrin in vitro also exist in vivo. The results obtained 
with X16 suggest hat, in addition, a pool of free LCa light 
chain can be found in vivo. 
One result hat is still unexplained is the predominance of
the LCa light chain seen in immunoprecipitates obtained with 
the anti-heavy chain MAbs, X 19 and X22. This is unexpected 
because the light chains of bovine brain clathrin purified in 
vitro apparently have a random distribution in their associa- 
tion with heavy chain in triskelions (12). A simple xplanation 
is that lymphoid cell clathrin might contain predominantly 
LCa light chain and that the 1:2 ratio of LCa/LCb light chain, 
found in brain tissue, is not typical of other tissues (9, 10). 
However, the variation in amounts of immunoprecipitated 
LCb suggests hat an additional factor may influence the LCd 
LCb ratio in immunoprecipitates. One possibility is that tri- 
skelions and even coated vesicles in vivo may have a nonran- 
dom distribution of the two light chains. More experiments 
on light chain quantitation i different issues and the devel- 
opment of an anti-LCb MAb are needed to clarify the question 
of light chain distribution in vivo. 
Immunoprecipitation after pulse-chase labeling showed 
that the amount of free LCa immunoprecipitated by the X 16 
MAb decreased gradually after biosynthesis but could be 
detected for as long as 7 h. Within I h after biosynthesis the 
amount of free LCa detected was less than half of that detected 
just after pulse labeling. Parallel experiments with X22 
showed that labeled clathrin heavy chain and light chain were 
increasingly incorporated into coated vesicles for up to 4 h. 
After 4 h, the amount of labeled clathrin in coated vesicles 
dropped slightly and then remained constant for at least 22 
h. This indicates there is little turnover of the heavy chain 
and light chain involved in coated vesicle formation within a 
22-h period. The fact that the heavy chain and associated light 
chain appear in coated vesicles with similar kinetics uggests 
that they are either incorporated simultaneously or become 
associated with each other as triskelions before assembly. 
Since the rate of free LCa disappearance was more rapid than 
that of coated vesicle formation, light chain and heavy chain 
probably form triskelions before assembly occurs. Comparing 
the kinetics of reduction of the free LCa pool with those of 
coated vesicle formation also suggests that the association of 
LCa with heavy chain is irreversible once the complex has 
been incorporated into a coated vesicle. This implies that LCa 
remains associated with heavy chain when coated vesicles 
depolymerize. 
The kinetics of clathrin biosynthesis determined above were 
found to be equivalent in lymphoid cell lines derived from a 
bovine leukemia cell and an Epstein Barr virus-transformed 
human B cell. Although, it is possible that the kinetics of 
clathrin biosynthesis may vary among cell types, it is still 
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interesting to compare these results with the biosynthesis of 
other proteins composed of multiple subunits. Class I histo- 
compatibility antigen heavy chain and #2-microglobulin light 
chain associate within 15 min after biosynthesis, and this 
association is required for expression on the cell surface (20, 
27). Vimentin, which is initially synthesized as a soluble 
cytoplasmic precursor, becomes completely associated with 
the cytoskeleton by polymerization into intermediate fila- 
ments within 2 h, and the soluble form has a half life of 7 
rain (28). Most newly synthesized a-spectrin is found in a 
cytoplasmic pool; either the pool rapidly associates with the 
/~-spectrin in the cytoskeleton, or the excess is degraded with 
a half-life of 45-60 min (29, 30). It is possible that, similar to 
a-spectrin, LCa is synthesized in excess of heavy chain, and 
reduction of the free pool detected by X I6 indicates the 
degradation rate of LCa that has not associated with heavy 
chain. It is also possible that the reduction of free LCa directly 
reflects the rate at which LCa becomes associated with heavy 
chain and is therefore no longer detectable with the X16 
MAb. These two explanations will be resolved when methods 
for quantitive immunoprecipitation have been worked out. 
Further experiments will also be required to determine the 
kinetics of light chain-heavy chain association before coated 
vesicle formation, and whether a pool of heavy chain mono- 
mers or trimers (31) exists that might interact with the free 
light chain pool. Such investigations will become possible as 
more monoclonal antibodies with specificity for clathrin in 
different structural forms are produced. 
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